Search Results 651-660 of 11022 for total t4

1. A Study to Evaluate Durvalumab Alone or in Combination With Novel Agents in Subjects With NSCLC - Mayo Clinic

   The purpose of this study is to compare the clinical activity of durvalumab alone vs durvalumab in combination with novel agents. The overall study goal is ...

2. Aggressive Smoldering Curative Approach Evaluating Novel Therapies and Transplant - Mayo Clinic

   Total score of 9 or above using the following scoring system: ... FiSH abnormality (t(4,14), t(14,16), 1q gain, or ... Total bilirubin ≤ 1.5 x ULN;; ALT ...

3. A Trial to Evaluate the Efficacy and Safety of Reldesemtiv in Patients with Amyotrophic Lateral Sclerosis (ALS) - Mayo Clinic

   muscles. - ALSFRS-R total score ≤ 44 at screening. Patients with a total score of 45 or higher may be rescreened 60±7 days following the original screening ...

4. A Phase 1/2a Dose-Finding Study of PT-112 in Patients With Relapsed or Refractory Multiple Myeloma - Mayo Clinic

   Total bilirubin ≤ 1.5 x ULN or direct bilirubin ≤ 1.5 x ULN when total bilirubin is > 1.5 x ULN;; Calculated creatinine clearance (CrCl) ≥ 30 mL/min ...

5. Reduced-Dose Angiography CT Imaging - Clinical Trials

   Current 3DA contributes substantially to the overall patient radiation dose for these procedures. The purpose of this work is to assess the clinical ...

6. Testing the Effects of Novel Therapeutics for Newly Diagnosed, Untreated Patients With High-Risk Acute Myeloid Leukemia (A MyeloMATCH Treatment Trial) - Mayo Clinic

   * Complete blood count (CBC)/differential/platelets * Total bilirubin * Lactate dehydrogenase (LDH) * Albumin * Glucose * Fibrinogen * Participants must ...

7. Chronic Lymphocytic Clinical Trials

   The primary objective of this study is to evaluate overall response rate (ORR) following treatment with idelalisib plus rituximab in participants with ...

8. Clinical trials - Oncology (Medical)

   ... overall survival compared to DRd consolidation followed by DR maintenance, in MRD positive patients. A Study to Evaluate Same Day Discharge Post-mastectomy ...

9. A Study of LOXO-292 in Patients with Advanced Solid Tumors, RET Fusion-Positive Solid Tumors, and Medullary Thyroid Cancer - Mayo Clinic

   Total bilirubin ≤ 1.5 × ULN or ≤ 3 × ULN with documented liver involvement (patients with Gilbert's Disease may be enrolled with prior Sponsor approval).

10. Rectal cancer surgery - Doctors & Departments - Mayo Clinic

    Transanal total mesorectal excision for rectal cancer. Advances in Surgery. 2025; doi:10.1016/j.yasu.2025.04.004.0065-3411/25. Dowli A, et al. Primary ...